CLASS II Drug recall · Reported 11 Jul 2018 · FDA Enforcement Report

Fentanyl (as citrate) 10 mcg/mL in 0.9% Sodium Chloride recalled

SCA Pharmaceuticals is recalling Fentanyl (as citrate) 10 mcg/mL in 0.9% Sodium Chloride, SCA Pharmaceuticals, LLC, distributed nationwide in the US. The recall was initiated on 14 Jun 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot # 20180328@19, 20180328@31, 20180328@39, 20180328@49, 20180328@53, 20180328@58, 20180323@9, 20180327@33, Exp 6/26/2018
Quantity recalled492 bags

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0895-2018
FDA event ID
80303
Recalling firm
SCA Pharmaceuticals, Windsor, CT
Classification
Class II
Status
Terminated
Recall initiated
14 Jun 2018
FDA classified
2 Jul 2018
Reported
11 Jul 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility
Drug class
Pain Medication

Timeline

14 Jun 2018Recall initiated by company
2 Jul 2018Classified by FDA+18 days
11 Jul 2018Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Fentanyl (as citrate) 10 mcg/mL in 0.9% Sodium Chloride 250 mL bag, SCA Pharmaceuticals, LLC, Windsor, CT

Where it was distributed

Product was distributed throughout the United States.

Nationwide

Questions about this recall

Why was it recalled?

Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.

Which lots are affected?

Lot # 20180328@19, 20180328@31, 20180328@39, 20180328@49, 20180328@53, 20180328@58, 20180323@9, 20180327@33, Exp 6/26/2018

Where was it sold?

Product was distributed throughout the United States.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

11 other products · FDA event 80303

This product is part of a recall event; the main page for the event is Norepinephrine Bitartrate 8 mg (32 mcg/mL) recalled.

More recalls from SCA Pharmaceuticals

All 166

Other Fentanyl (as recalls

All 8